Biofrontera Inc.
BFRI· Nasdaq
BFRIBiofrontera Inc.
Filed Mar 13, 2023 · 10-K · 72 days after period end · 0001493152-23-007472
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | $10.14M | $9.17M | — |
| Net Income | -$2.79M | -$14.51M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 13, 2023 · 72 d after period end
